What is the diagnosis and treatment for a tonsillar abscess (peritonsillar abscess)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Tonsillar abscess treatment should prioritize antibiotics and drainage of the abscess, with consideration for pain management and hydration, as recommended by the most recent guidelines 1.

Key Considerations

  • The recommended antibiotic regimen includes penicillin (such as amoxicillin-clavulanate 875/125 mg twice daily) or clindamycin 300-450 mg four times daily for patients with penicillin allergy, for 10-14 days.
  • Drainage is essential and can be performed via needle aspiration or incision and drainage by an otolaryngologist or emergency physician.
  • Pain management with acetaminophen or ibuprofen is important, and patients should stay hydrated and may need to consume soft foods temporarily.

Tonsillar Abscess Formation

Tonsillar abscesses form when bacterial infections, often following tonsillitis, spread into the surrounding tissue. The most common bacteria involved are Streptococcus species and anaerobes.

Importance of Prompt Treatment

Without proper treatment, the infection can spread to deeper tissues of the neck or even the bloodstream, making prompt medical care crucial. If symptoms worsen despite treatment, including increased difficulty swallowing, breathing problems, or spreading infection, immediate medical attention is necessary.

Guideline Recommendations

The American Academy of Otolaryngology-Head and Neck Surgery recommends watchful waiting for recurrent throat infection if there have been fewer than 7 episodes in the past year, fewer than 5 episodes per year in the past 2 years, or fewer than 3 episodes per year in the past 3 years 1. Additionally, the guidelines suggest that clinicians should assess the child with recurrent throat infection who does not meet criteria for modifying factors that may favor tonsillectomy, which may include multiple antibiotic allergies/intolerance, PFAPA, or history of peritonsillar abscess 1.

From the FDA Drug Label

Clindamycin Injection, USP is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. Clindamycin Injection, USP is indicated in the treatment of serious infections caused by susceptible strains of the designated organisms in the conditions listed below: Intra-abdominal infections including peritonitis and intra-abdominal abscess caused by susceptible anaerobic organisms.

The FDA drug label does not answer the question about Tonseral abscess.

From the Research

Definition and Diagnosis of Peritonsillar Abscess

  • Peritonsillar abscess (PTA) is a collection of pus located between the tonsillar capsule and the pharyngeal constrictor muscle 2.
  • The presenting symptoms of PTA include fever, throat pain, and trismus 3.
  • Ultrasonography and computed tomographic scanning are useful in confirming a diagnosis of PTA 3.
  • Needle aspiration remains the gold standard for diagnosis and treatment of peritonsillar abscess 3, 4.

Treatment of Peritonsillar Abscess

  • Appropriate antibiotic therapy, including penicillin, clindamycin, cephalosporins, or metronidazole, must be initiated after performing aspiration 3.
  • In advanced cases, incision and drainage or immediate tonsillectomy may be required 3, 4.
  • Immediate tonsillectomy in patients with peritonsillar abscess is a safe and effective treatment that should be considered as an alternative to conventional incision and drainage 5.
  • Needle aspiration is an effective first-line procedure for patients with PTA, and tonsillectomy is not necessary in most cases 6.

Microbiology of Peritonsillar Abscess

  • Group A streptococcus (GAS) is the only established pathogen in PTA, but it is only recovered from approximately 20% of PTA patients 2.
  • Fusobacterium necrophorum (FN) is a significant and prevalent pathogen in PTA, and it is associated with increased risk of PTA development 2.
  • The microbiology of PTA fluctuates with seasons, with GAS-positive PTA cases being more prevalent in the winter and spring, and FN-positive PTA patients exhibiting a more even distribution over the year 2.

Risk Factors and Complications

  • Smoking is associated with increased risk of PTA for both genders and across all age groups 2.
  • The incidence of PTA is highly related to age and gender, with teenagers and young adults being most commonly affected 2.
  • Complications of PTA include parapharyngeal abscess, upper airway obstruction, Lemierre's syndrome, necrotizing fasciitis, mediastinitis, erosion of the internal carotid artery, brain abscess, and streptococcal toxic shock syndrome 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Peritonsillar abscess: diagnosis and treatment.

American family physician, 2002

Research

Peritonsillar infections.

Otolaryngologic clinics of North America, 1987

Related Questions

How to describe dysphonia on physical exam in a patient with a tonsillar abscess?
Can gonorrhoea cause peritonsillar abscesses?
What is the recommended course of action for a 10-year-old patient who has shown improvement after intravenous (IV) antibiotics for a tonsillar abscess, but has only completed 1 week of oral antibiotics?
What are the implications of Class 1 tonsils (tonsillar hypertrophy grade 1) for dental clearance?
What is the patient education for a peritonsillar abscess (PTA)?
What is the diagnosis and treatment plan for a 45-year-old woman with Type 2 Diabetes Mellitus, Dyslipidemia, and Hypertension, presenting with muscle cramps, weakness, diarrhea, and dizziness, on Metformin, Lisinopril, Bisoprolol, and Pravastatin?
When should intravenous (IV) albumin be used?
What is the diagnosis for a patient with mild peripheral reticulonodular infiltrates in the anterior lung bases and posterior upper lobes, mild right hilar adenopathy (12 mm), and 12 mm precarinal adenopathy, with unremarkable pleural spaces, heart, and lymph nodes?
What is the safety and efficacy of Boswellia serrata for joint health?
What are the primary concerns and suggested interventions for a 45-year-old woman with Type 2 Diabetes Mellitus (DM), hypertension (HTN), dyslipidemia, and obesity, presenting with muscle cramps, weakness, numbness, diarrhea, and dizziness, while taking Metformin (metformin), Lisinopril (lisinopril), Bisoprolol (bisoprolol), and Pravastatin (pravastatin), with lab results indicating hyperkalemia, hyperglycemia, and elevated lipid profiles?
What are the implications of modest degenerative osteoarthritic (degenerative joint disease) changes at the left hip joint?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.